These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34407441)

  • 1. Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial.
    Koshak AE; Koshak EA; Mobeireek AF; Badawi MA; Wali SO; Malibary HM; Atwah AF; Alhamdan MM; Almalki RA; Madani TA
    Complement Ther Med; 2021 Sep; 61():102769. PubMed ID: 34407441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial.
    Koshak AE; Koshak EA; Mobeireek AF; Badawi MA; Wali SO; Malibary HM; Atwah AF; Alhamdan MM; Almalki RA; Madani TA
    Trials; 2020 Aug; 21(1):703. PubMed ID: 32771034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
    Bosaeed M; Mahmoud E; Hussein M; Alharbi A; Alsaedy A; Alothman A; Aljeraisy M; Alqahtani H; Nashabat M; Almutairi B; Almaghaslah M; Aldibasi O; AlJohani S; Bouchama A; Arabi Y; Alaskar A
    Trials; 2020 Oct; 21(1):904. PubMed ID: 33129363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nigella sativa Supplementation Improves Asthma Control and Biomarkers: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Koshak A; Wei L; Koshak E; Wali S; Alamoudi O; Demerdash A; Qutub M; Pushparaj PN; Heinrich M
    Phytother Res; 2017 Mar; 31(3):403-409. PubMed ID: 28093815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of
    Said SA; Abdulbaset A; El-Kholy AA; Besckales O; Sabri NA
    Front Pharmacol; 2022; 13():1011522. PubMed ID: 36425571
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylactic potential of honey and Nigella sativa L. against hospital and community-based SARS-CoV-2 spread: a structured summary of a study protocol for a randomised controlled trial.
    Ashraf S; Ashraf S; Akmal R; Ashraf M; Kalsoom L; Maqsood A; Imran MA; Farooq I; Ashraf S; Siddiqui UN; Ghufran M; Akram MK; Majeed N; Rafique S; Habib Z; Shahab MS; Akmal A; Shaukat Z; Abdin ZU; Khaqan A; Arshad S; Rehman Virk MA; Gul M; Awais AB; Hassan M; Khalid N; Iqbal QUA; Ahmad T; Akram M; Muhammad A; Khalil M; Aslam A; Umer M; Sherazi SSH; Safdar Z; Ahmad S; Bilal M; Zahid MN; Koshak AE; Hilal A; Malik AA; Iqbal U; Baig AA; Alahmadi YM; Humayun A; Malik A; Ahmad A; Ashraf M; Saboor QA; Izhar M;
    Trials; 2021 Sep; 22(1):618. PubMed ID: 34526081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Short Treatment with Nigella Sativa on Symptoms, the Cluster of Differentiation (CD) Profile, and Inflammatory Markers in Mild COVID-19 Patients: A Randomized, Double-Blind Controlled Trial.
    Bin Abdulrahman KA; Bamosa AO; Bukhari AI; Siddiqui IA; Arafa MA; Mohsin AA; Althageel MF; Aljuaeed MO; Aldeailej IM; Alrajeh AI; Aldosari KM; Hawsawi NA; Zawbaee KI; Alsurayea SM
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36142070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.
    Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM
    Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
    Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
    Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multicenter placebo-controlled randomized clinical trial.
    Ashraf S; Ashraf S; Ashraf M; Imran MA; Kalsoom L; Siddiqui UN; Farooq I; Akmal R; Akram MK; Ashraf S; Ghufran M; Majeed N; Habib Z; Rafique S; -Abdin ZU; Arshad S; Shahab MS; Ahmad S; Zheng H; Mirza AR; Zulfiqar S; Anwar MI; Humayun A; Mahmud T; Saboor QA; Ahmad A; Ashraf M; Izhar M;
    Phytother Res; 2023 Feb; 37(2):627-644. PubMed ID: 36420866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial.
    Zhang C; Li J; Wu Z; Wang H; Que C; Zhao H; Wang G
    Trials; 2020 Jun; 21(1):495. PubMed ID: 32513299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial.
    Hosogaya N; Miyazaki T; Fukushige Y; Takemori S; Morimoto S; Yamamoto H; Hori M; Kurokawa T; Kawasaki Y; Hanawa M; Fujii Y; Hanaoka H; Iwami S; Watashi K; Yamagoe S; Miyazaki Y; Wakita T; Izumikawa K; Yanagihara K; Mukae H; Kohno S;
    Trials; 2021 Apr; 22(1):309. PubMed ID: 33910617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.
    Takayama S; Namiki T; Ito T; Arita R; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Kainuma M; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T
    Trials; 2020 Oct; 21(1):827. PubMed ID: 33008479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate COVID-19: A Phase 2 Randomized Clinical Trial.
    Cairns DM; Dulko D; Griffiths JK; Golan Y; Cohen T; Trinquart L; Price LL; Beaulac KR; Selker HP
    JAMA Netw Open; 2022 Feb; 5(2):e2144942. PubMed ID: 35138402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial.
    Li J; Zhang C; Wu Z; Wang G; Zhao H
    Trials; 2020 Jun; 21(1):488. PubMed ID: 32503657
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Imran M; Khan SA; Abida ; Alshammari MK; Alkhaldi SM; Alshammari FN; Kamal M; Alam O; Asdaq SMB; Alzahrani AK; Jomah S
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.